抗抑郁药物是来自Hypericum ascyron的多烯酸黄醇
En-Hui Zhang1, Yu Chen2, Lei Zhang2
1Department of Pharmacy, The 967th Hospital of Joint Logistic Support Force of PLA, Dalian 116041, China.
Journal of Asian natural products research
|August 23, 2023
概括
从Hypericum ascyron中分离出了三种新的化合物,即阿斯基罗宁A-C. 化合物2和3通过抑制血清素再吸收,显示出较弱的抗抑郁作用.
科学领域:
- 自然产品化学 自然产品化学
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- Hypericum ascyron是一种具有潜在药用特性的植物物种.
- 植物化学研究旨在识别植物来源的生物活性化合物.
- 了解药用植物的化学成分对于药物发现至关重要.
研究的目的:
- 从Hypericum ascyron中分离和表征新的多环聚乙烯酸黄醇.
- 评估分离化合物的抗抑郁药物潜力.
主要方法:
- 对Hypericum ascyron.上空部分90%的EtOH提取物的植物化学分析.
- 使用1D和2DNMR光谱 (1H-1H COSY,HMQC,HMBC) 的结构阐明.
- 通过抑制大鼠大脑突触体中的 [3H] - 色胺和 [3H] - 诺阿德林林再吸收来评估抗抑郁药物的活性.
主要成果:
- 分离了三种新的多环聚衍生物,阿斯基罗宁A-C (1-3).
- 通过使用综合光谱方法确认了这些结构.
- 化合物2和3通过抑制 [3H] - 血清素再吸收,显示出较弱的抗抑郁作用.
结论:
- 这项研究成功地发现了来自Hypericum ascyron的新型化合物.
- 阿西罗宁2和3具有温和的抗抑郁药物特性,需要进一步研究.
- 这项研究有助于了解Hypericum ascyron的化学多样性和药理潜力.
更多相关视频
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
1.5K
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
93
相关概念视频
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
435
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
435
01:25Antidepressant Drugs: Overview
565
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
565
01:21Drugs for Treatment of Constipation-Predominant IBS
206
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
206
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
303
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
303
01:23Antidepressant Drugs: MAOIs and Other Agents
272
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
272
01:17Drugs for Treatment of Diarrhea-Predominant IBS
212
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
212